Literature DB >> 26685999

Formation of Nup98-containing nuclear bodies in HeLa sublines is linked to genomic rearrangements affecting chromosome 11.

Serge Romana1, Isabelle Radford-Weiss1, Jean-Michel Lapierre1, Valérie Doye2, Marie-Claude Geoffroy3.   

Abstract

Nup98 is an important component of the nuclear pore complex (NPC) and also a rare but recurrent target for chromosomal translocation in leukaemogenesis. Nup98 contains multiple cohesive Gly-Leu-Phe-Gly (GLFG) repeats that are critical notably for the formation of intranuclear GLFG bodies. Previous studies have reported the existence of GLFG bodies in cells overexpressing exogenous Nup98 or in a HeLa subline (HeLa-C) expressing an unusual elevated amount of endogenous Nup98. Here, we have analysed the presence of Nup98-containing bodies in several human cell lines. We found that HEp-2, another HeLa subline, contains GLFG bodies that are distinct from those identified in HeLa-C. Rapid amplification of cDNA ends (RACE) revealed that HEp-2 cells express additional truncated forms of Nup98 fused to a non-coding region of chromosome 11q22.1. Cytogenetic analyses using FISH and array-CGH further revealed chromosomal rearrangements that were distinct from those observed in leukaemic cells. Indeed, HEp-2 cells feature a massive amplification of juxtaposed NUP98 and 11q22.1 loci on a chromosome marker derived from chromosome 3. Unexpectedly, minor co-amplifications of NUP98 and 11q22.1 loci were also observed in other HeLa sublines, but on rearranged chromosomes 11. Altogether, this study reveals that distinct genomic rearrangements affecting NUP98 are associated with the formation of GLFG bodies in specific HeLa sublines.

Entities:  

Keywords:  Homogeneously staining region; Leukaemia; Nucleoporin; Nup98

Mesh:

Substances:

Year:  2015        PMID: 26685999     DOI: 10.1007/s00412-015-0567-0

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  53 in total

1.  Patterns of variant polyadenylation signal usage in human genes.

Authors:  E Beaudoing; S Freier; J R Wyatt; J M Claverie; D Gautheret
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

2.  Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia.

Authors:  C Graux; M Stevens-Kroef; M Lafage; N Dastugue; C J Harrison; F Mugneret; K Bahloula; S Struski; M J Grégoire; N Nadal; E Lippert; S Taviaux; A Simons; R P Kuiper; A V Moorman; K Barber; A Bosly; L Michaux; P Vandenberghe; I Lahortiga; K De Keersmaecker; I Wlodarska; J Cools; A Hagemeijer; H A Poirel
Journal:  Leukemia       Date:  2008-10-16       Impact factor: 11.528

3.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Marta Pratcorona; Saman Abbas; Jenny E Kuipers; Janneke F van Galen; H Berna Beverloo; Edwin Sonneveld; Gert-Jan J L Kaspers; Jan Trka; Andre Baruchel; Martin Zimmermann; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; Peter J M Valk; C Michel Zwaan
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

Review 4.  Nuclear pore complexes: guardians of the nuclear genome.

Authors:  M Capelson; C Doucet; M W Hetzer
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-04-18

5.  The role of Nup98 in transcription regulation in healthy and diseased cells.

Authors:  Tobias M Franks; Martin W Hetzer
Journal:  Trends Cell Biol       Date:  2012-12-13       Impact factor: 20.808

6.  The genomic and transcriptomic landscape of a HeLa cell line.

Authors:  Jonathan J M Landry; Paul Theodor Pyl; Tobias Rausch; Thomas Zichner; Manu M Tekkedil; Adrian M Stütz; Anna Jauch; Raeka S Aiyar; Gregoire Pau; Nicolas Delhomme; Julien Gagneur; Jan O Korbel; Wolfgang Huber; Lars M Steinmetz
Journal:  G3 (Bethesda)       Date:  2013-08-07       Impact factor: 3.154

7.  t(12;21): a new recurrent translocation in acute lymphoblastic leukemia.

Authors:  S P Romana; M Le Coniat; R Berger
Journal:  Genes Chromosomes Cancer       Date:  1994-03       Impact factor: 5.006

8.  RAE1 is a shuttling mRNA export factor that binds to a GLEBS-like NUP98 motif at the nuclear pore complex through multiple domains.

Authors:  C E Pritchard; M Fornerod; L H Kasper; J M van Deursen
Journal:  J Cell Biol       Date:  1999-04-19       Impact factor: 10.539

9.  Novel vertebrate nucleoporins Nup133 and Nup160 play a role in mRNA export.

Authors:  S Vasu; S Shah; A Orjalo; M Park; W H Fischer; D J Forbes
Journal:  J Cell Biol       Date:  2001-10-29       Impact factor: 10.539

10.  Proteomic analysis of the mammalian nuclear pore complex.

Authors:  Janet M Cronshaw; Andrew N Krutchinsky; Wenzhu Zhang; Brian T Chait; Michael J Matunis
Journal:  J Cell Biol       Date:  2002-08-26       Impact factor: 10.539

View more
  4 in total

1.  Disentangling the molecular determinants for Cenp-F localization to nuclear pores and kinetochores.

Authors:  Alessandro Berto; Jinchao Yu; Stéphanie Morchoisne-Bolhy; Chiara Bertipaglia; Richard Vallee; Julien Dumont; Francoise Ochsenbein; Raphael Guerois; Valérie Doye
Journal:  EMBO Rep       Date:  2018-04-09       Impact factor: 8.807

2.  The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)+ RNA Export.

Authors:  Sarah A Port; Adélia Mendes; Christina Valkova; Christiane Spillner; Birthe Fahrenkrog; Christoph Kaether; Ralph H Kehlenbach
Journal:  J Biol Chem       Date:  2016-09-09       Impact factor: 5.157

Review 3.  Nucleoporins in cardiovascular disease.

Authors:  Ryan D Burdine; Claudia C Preston; Riley J Leonard; Tyler A Bradley; Randolph S Faustino
Journal:  J Mol Cell Cardiol       Date:  2020-03-21       Impact factor: 5.000

Review 4.  Nucleoplasmic Nup98 controls gene expression by regulating a DExH/D-box protein.

Authors:  Juliana S Capitanio; Ben Montpetit; Richard W Wozniak
Journal:  Nucleus       Date:  2017-09-21       Impact factor: 4.197

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.